Trial NCT04816214

View at ClinicalTrials.gov 
Org. Study IDs: CINC280L12301
Secondary IDs: 2020-003677-21

Last trial update was posted on 2024-03-05

MeSH Interventions

Carboplatin Osimertinib Pemetrexed

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions


Stopping Reasons

Novartis decided to terminate the study based on a business consideration and not related with any safety concerns. Randomized part was not initiated

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID